Leerink Global Healthcare Conference 2026
Logotype for CVS Health Corporation

CVS Health (CVS) Leerink Global Healthcare Conference 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

Leerink Global Healthcare Conference 2026 summary

9 Mar, 2026

Strategic vision and integration

  • Leadership is focused on integrating pharmacy, PBM, and healthcare delivery assets to create a differentiated consumer experience across 9,000 community pharmacies and primary care locations.

  • Recent acquisitions and partnerships, such as Oak Street, Signify, and Cordavis, are leveraged to drive affordability and access, including launching biosimilars with significant cost savings.

  • Technology investments have improved store operations, consumer-facing applications, and enabled seamless prescription transfers and benefit visibility.

  • Expansion of pharmacists' roles and capacity is a priority, aiming to provide more non-acute and non-chronic care solutions.

  • The enterprise strategy emphasizes connecting assets to enhance consumer convenience and drive better healthcare outcomes.

Regulatory and market adaptation

  • Recent PBM legislation aligns with the transparent TrueCost model, which offers drug-level specific pricing and is being phased in ahead of regulatory deadlines (late 2028–early 2029).

  • The transition to new PBM models is expected to maintain durable margins, with mid-teens CAGR targeted through 2028.

  • The organization is actively managing rebate guarantee pressures and recontracting processes, with $500 million in headwinds spread through 2026.

  • Adjustments to drug pricing models, such as TrueCost, are designed to neutralize list price volatility and focus on net costs.

  • Strong selling season for 2026 with over $6 billion in net new revenue and high client retention (>98%).

Pharmacy and reimbursement evolution

  • CostVantage was implemented to address reimbursement erosion, shifting to a transparent, fixed-margin per script model for predictability and stability.

  • The pharmacy footprint has been optimized to 9,000 locations, with opportunistic expansion through Rite Aid file acquisitions.

  • The pharmacy of the future is envisioned as a hub for more clinical care, integrated digital experiences, and standardized service delivery.

  • Competitive landscape now includes national chains, independents, grocery stores, and disruptive innovators, with a focus on leveraging technology and scale.

  • CostVantage aims for stable, equitable reimbursement rather than margin expansion.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more